Learn more or see if you may qualify at https://telehealthfx.com

Educational content only — not medical advice. Talk to a licensed clinician before starting any medication. Telehealth FX is an informational and affiliate platform, not a medical provider or pharmacy, and may earn a commission. Compounded medications are not FDA-approved. Individual results vary.

Tirzepatide is the medication behind Mounjaro and Zepbound — and unlike single-receptor GLP-1s, it's a dual GIP/GLP-1 agonist. In this episode we explain what tirzepatide is, how the two-receptor mechanism works, the difference between the brands, what the research shows for weight and blood sugar, how it compares to semaglutide, and why it recently became the first medication ever approved for obstructive sleep apnea — plus the real side effects and the honest truth about stopping.

Quick clarifier: tirzepatide is the active drug. Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight management and, as of December 2024, for moderate-to-severe obstructive sleep apnea in adults with obesity.

Key facts: In SURMOUNT-1, average weight loss ranged from about 16% to 22.5% over 72 weeks. In the head-to-head SURMOUNT-5 trial, tirzepatide produced about 20.2% weight loss versus 13.7% for semaglutide. In SURMOUNT-OSA, the highest tolerated doses were associated with roughly 25–29 fewer apnea/hypopnea events per hour versus placebo. Across follow-up studies, people regained roughly two-thirds of lost weight within a year of stopping.

Real risks discussed: gastrointestinal side effects; a boxed warning for thyroid C-cell tumors (not for those with a personal/family history of medullary thyroid carcinoma or MEN2); pancreatitis and gallbladder risks; a class warning for ileus (intestinal blockage). Note: a large analysis did not find a significant link between tirzepatide and the rare optic-nerve condition associated with semaglutide, though research continues.

Important: Compounded tirzepatide is not FDA-approved — the FDA does not evaluate it for safety, effectiveness, or quality — and it is not the same as branded Mounjaro or Zepbound. Prescription medications require evaluation and a prescription from a licensed clinician, and eligibility is individual. Individual results vary.

Learn more or see if you may qualify at https://telehealthfx.com

#Tirzepatide #Mounjaro #Zepbound #WeightManagement #SleepApnea #GLP1 #HealthEducation #Telehealth